Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 2/2008

01-12-2008 | Online Report

l-2-Hydroxyglutaric aciduria: Clinical and molecular study in three Tunisian families. Identification of a new mutation and inter-familial phenotype variability

Authors: A. Larnaout, R. Amouri, M. Kefi, F. Hentati

Published in: Journal of Inherited Metabolic Disease | Special Issue 2/2008

Login to get access

Summary

We report clinical and molecular studies in three unrelated Tunisian families containing seven patients with L2HGA. Although the age of onset is similar in all these patients at nearly 6 years, they progressively developed peculiar clinical phenotypes different from family to family. The three patients of family 1 showed mental retardation, epilepsy, cerebellar ataxia and pyramidal and pseudobulbar syndromes. The two patients of family 2 showed mental retardation and parkinsonism especially extrapyramidal stiffness, dystonia and myoclonus. The two patients of family 3 showed an intermediate phenotype; they share some clinical signs of the patients of family 1 (epilepsy, pyramidal and extrapyramidal syndromes) and some clinical signs of the patients of family 2 (extrapyramidal stiffness and dystonia). Molecular study identified a novel homozygous c.185C > A, p.A62D mutation on the L2HGDH gene in families 1 and 3 and the already known homozygous c.241A > G, p.K81E mutation in family 2. We suppose that the type of mutation in the L2HGDH gene does not play a complete role in the inter-familial phenotype variability. Disturbance of other unknown metabolic pathways related to L2HGA may contribute to this phenomenon.
Literature
go back to reference Ben-zeev B, Gross V, Kushnir T, et al (2001) Vacuolating megalencephalic leukoencephalopathy in 12 Israeli patients. J Child Neurol 16(2): 93–99.PubMed Ben-zeev B, Gross V, Kushnir T, et al (2001) Vacuolating megalencephalic leukoencephalopathy in 12 Israeli patients. J Child Neurol 16(2): 93–99.PubMed
go back to reference Lee C, Born M, Salomons GS, Jacobs C, Woelfle J (2006) Hemiconvulsion-hemiplegia-epilepsy syndrome as a presenting feature of l-2-hydroxyglutaric aciduria. J Child Neurol 21(6): 538–540.PubMed Lee C, Born M, Salomons GS, Jacobs C, Woelfle J (2006) Hemiconvulsion-hemiplegia-epilepsy syndrome as a presenting feature of l-2-hydroxyglutaric aciduria. J Child Neurol 21(6): 538–540.PubMed
go back to reference Moroni I, Bugiani M, D’Incerti I, et al (2004) l-2-Hydroxyglutaric aciduria and brain malignant tumors, a predisposing condition. Neurology 62: 1882–1884.PubMed Moroni I, Bugiani M, D’Incerti I, et al (2004) l-2-Hydroxyglutaric aciduria and brain malignant tumors, a predisposing condition. Neurology 62: 1882–1884.PubMed
go back to reference Rzem R, Veiga-da-Cunha M, Noel G, et al (2004) A gene encoding a putative FAD-dependant l-2-hydroxyglutarate dehydrogenase is mutated in l-2-hydroxyglutaric aciduria. Proc Natl Acad Sci U S A 101(48): 16849–16854. doi:10.1073/pnas.0404840101.PubMedCrossRef Rzem R, Veiga-da-Cunha M, Noel G, et al (2004) A gene encoding a putative FAD-dependant l-2-hydroxyglutarate dehydrogenase is mutated in l-2-hydroxyglutaric aciduria. Proc Natl Acad Sci U S A 101(48): 16849–16854. doi:10.​1073/​pnas.​0404840101.PubMedCrossRef
go back to reference Sass JO, Jobard F, Topçu M, et al (2008) l-2-Hydroxyglutaric aciduria: identification of ten novel mutations in the L2HGDH gene. J Inherit Metab Dis. doi:10.1007/s10545-008-0855-4. Sass JO, Jobard F, Topçu M, et al (2008) l-2-Hydroxyglutaric aciduria: identification of ten novel mutations in the L2HGDH gene. J Inherit Metab Dis. doi:10.​1007/​s10545-008-0855-4.
go back to reference Shafeghati Y, Vakili G, Entezari A (2006) l-2-Hydroxyglutaric aciduria: a report of six cases and review of the literature. Arch Iran Med 9(2): 165–169.PubMed Shafeghati Y, Vakili G, Entezari A (2006) l-2-Hydroxyglutaric aciduria: a report of six cases and review of the literature. Arch Iran Med 9(2): 165–169.PubMed
go back to reference Topcu M, Jouhard F, Halliaz S, et al (2004) l-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum Mol Genet 13(22): 2803–2811.PubMedCrossRef Topcu M, Jouhard F, Halliaz S, et al (2004) l-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum Mol Genet 13(22): 2803–2811.PubMedCrossRef
go back to reference Yilmaz K (2008) Riboflavin treatment in a case with l-2-hydroxyglutaric aciduria. Eur J Paediatr Neurol 2008 Mar 14 [Epub ahead of print]. Yilmaz K (2008) Riboflavin treatment in a case with l-2-hydroxyglutaric aciduria. Eur J Paediatr Neurol 2008 Mar 14 [Epub ahead of print].
Metadata
Title
l-2-Hydroxyglutaric aciduria: Clinical and molecular study in three Tunisian families. Identification of a new mutation and inter-familial phenotype variability
Authors
A. Larnaout
R. Amouri
M. Kefi
F. Hentati
Publication date
01-12-2008
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue Special Issue 2/2008
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-008-0934-6

Other articles of this Special Issue 2/2008

Journal of Inherited Metabolic Disease 2/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.